CymaBay Announces Pricing of Upsized $225 Million Public Offering of Common Stock and Pre-Funded Warrants

By /

CymaBay Therapeutics, Inc. announced the pricing of its previously announced underwritten public offering of common stock and pre-funded warrants.

Scroll to Top